D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly.

Archive ouverte

Barroso-Chinea, Pedro | Thiolat, Marie-Laure | Bido, Simone | Martinez, Audrey | Doudnikoff, Evelyne | Baufreton, Jérôme | Bourdenx, Mathieu | Bloch, Bertrand | Bezard, Erwan | Martin-Negrier, Marie-Laure

Edité par CCSD ; Elsevier -

International audience. Among the mechanisms underlying the development of L-dopa-induced dyskinesia (LID) in Parkinson's disease, complex alterations in dopamine signaling in D1 receptor (D1R)-expressing medium spiny striatal neurons have been unraveled such as, but not limited to, dysregulation of D1R expression, lateral diffusion, intraneuronal trafficking, subcellular localization and desensitization, leading to a pathological anchorage of D1R at the plasma membrane. Such anchorage is partly due to a decreased proteasomal activity that is specific of the L-dopa-exposed dopamine-depleted striatum, results from D1R activation and feeds-back the D1R exaggerated cell surface abundance. The precise mechanisms by which L-dopa affects striatal proteasome activity remained however unknown. We here show, in a series of in vitro ex vivo and in vivo models, that such rapid modulation of striatal proteasome activity intervenes through D1R-mediated disassembly of the 26S proteasome rather than change in transcription or translation of proteasome or proteasome subunits intraneuronal relocalization.

Consulter en ligne

Suggestions

Du même auteur

L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor.

Archive ouverte | Berthet, Amandine | CCSD

International audience. Aberrant membrane localization of dopamine D(1) receptor (D1R) is associated with L-DOPA-induced dyskinesia (LID), a major complication of L-DOPA treatment in Parkinson's disease (PD). Since ...

L-DOPA Impairs Proteasome Activity in Parkinsonism through D1 Dopamine Receptor

Archive ouverte | Berthet, Amandine | CCSD

International audience. Aberrant membrane localization of dopamine D(1) receptor (D1R) is associated with L-DOPA-induced dyskinesia (LID), a major complication of L-DOPA treatment in Parkinson's disease (PD). Since ...

PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking

Archive ouverte | Porras, Gregory | CCSD

International audience. L-DOPA-induced dyskinesia (LID), a detrimental consequence of dopamine replacement therapy for Parkinson's disease, is associated with an alteration in dopamine D1 receptor (D1R) and glutamat...

Chargement des enrichissements...